Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × pixantrone × Tumor-Agnostic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 2 Tumor-Agnostic 1

Conditions

Neoplasm Metastasis 1

Interventions

Magnetic Resonance Spectroscopy 5 Cisplatin 5 Gemcitabine 4 trametinib 2 repotrectinib 2 pembrolizumab 2 enzalutamide 2 atezolizumab 2 Surveys and Questionnaires 2 SS1(dsFv)PE38 2 Radiotherapy, Intensity-Modulated 2 Radiotherapy 2 Radiosurgery 2 Paclitaxel 2 Nivolumab 2 Docetaxel 2 vinflunine 1 veliparib 1 vadimezan 1 toripalimab 1 talazoparib 1 sintilimab 1 reolysin 1 pixantrone 1 pertuzumab 1 peginterferon alfa-2a 1 palbociclib 1 onartuzumab 1 olaparib 1 nintedanib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01632436 2023-10-02

Hepatic

CTI BioPharma

Phase 1 Withdrawn

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡